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Activation of Delta Opioid Receptors Induces
Receptor Insertion and Neuropeptide Secretion
a lack of effect of morphine on CGRP release (Morton
and Hutchison, 1990) as well as DOR and MOR-medi-
ated, biphasic, and dose-dependent effects on SP re-
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Fang-Xiong Zhang,1 Lie-Chen Wang,2
Feng-Shou Ning,1 Hai-Jiang Cai,1 Ji-Song Guan,1 lease (Suarez-Roca and Maixner, 1992). There is also
evidence that simultaneous activation of MORs andHua-Sheng Xiao,1 Zhi-Qing D. Xu,3 Cheng He,1
Tomas Ho¨kfelt,3 Zhuan Zhou,2,* and Xu Zhang1,* kappa opioid receptors is required for inhibition of CGRP
release, whereas DOR stimulation increases CGRP re-1Laboratory of Sensory System
2 Laboratory of Cellular Biophysics lease (Collin et al., 1993). It is therefore of interest to
further elucidate mechanisms underlying DOR-medi-Institute of Neuroscience
Shanghai Institute of Biological Sciences ated regulation of neuropeptide release.
There are two secretory pathways in neurons, theChinese Academy of Sciences
Shanghai regulated and the constitutive pathway (De Camilli and
Jahn, 1990; Jung and Scheller, 1991). In the constitutiveChina
3 Department of Neuroscience pathway, proteins are secreted by a constant exocytosis
of microvesicles derived from the trans-Golgi networkKarolinska Institute
Stockholm in the absence of secretagogues. It is generally believed
that membrane components are inserted into theSweden
plasma membrane via this pathway. In the regulated
pathway, peptides/proteins stored in LDCVs or classic
neurotransmitters in synaptic vesicles are released uponSummary
stimulation by secretagogues. Recent studies have
shown that in DRG neurons, the majority of DORs (EvansHere we describe a novel mechanism for plasma mem-
brane insertion of the delta opioid receptor (DOR). In et al., 1992; Kieffer et al., 1992) are localized in the cyto-
plasm and are often associated with LDCVs (Cheng etsmall dorsal root ganglion neurons, only low levels of
DORs are present on the cell surface, in contrast to al., 1995; Zhang et al., 1998). We thus hypothesized that
insertion of DORs into the plasma membrane may behigh levels of intracellular DORs mainly associated
with vesicles containing calcitonin gene-related pep- associated with regulated exocytosis in response to no-
ciceptive stimuli, capsaicin (Mantyh et al., 1995; Caterinatide (CGRP). Activation of surface DORs caused Ca2
release from IP3-sensitive stores and Ca2 entry, re- et al., 1997), ATP (Nakatsuka et al., 2001), or depolariza-
tion (Huang and Neher, 1996), which are all known tosulting in a slow and long-lasting exocytosis, DOR
insertion, and CGRP release. In contrast, membrane trigger release of neuropeptides from these neurons.
In this study, we examine the coupling between regu-depolarization or activation of vanilloid and P2Y1 re-
ceptors induced a rapid DOR insertion. Thus, DOR lated exocytosis and membrane insertion of DORs and
find that activating DORs causes intracellular Ca2 re-activation induces a Ca2-dependent insertion of
DORs that is coupled to a release of excitatory neuro- lease and Ca2 entry, which leads to DOR insertion and
CGRP release. It is distinguished from DOR insertionpeptides, suggesting that treatment of inflammatory
pain should include blockade of DORs. mediated by the vanilloid receptor 1 (VR1) and P2Y1
purinergic receptor (P2Y1-R) or membrane depolariza-
tion by its slow and long-lasting regulated exocytosis.Introduction
Signals generated by nociceptive stimuli are transmitted Results
from peripheral processes of small dorsal root ganglion
(DRG) neurons to their central terminals in the dorsal DOR Agonist-Induced DOR Redistribution
horn of the spinal cord and cause release of, among We have previously shown that DORs associate with
others, the neuropeptides substance P (SP) and calcito- LDCVs in small neurons of rat and monkey DRGs (Zhang
nin gene-related peptide (CGRP), which are often stored et al., 1998). We now confirm this localization in mouse
in the same large dense-core vesicle (LDCV) (Merighi et DRGs using two antibodies raised against different frag-
al., 1988). Opioid receptors localize on primary afferents ments of the amino terminus of mouse DOR (N-DOR)
(Lamotte et al., 1976; Fields et al., 1980) and mediate at and one antibody against the carboxy terminus of DOR
least part of the analgesic effect by influencing transmis- (C-DOR). With both N-DOR (Figure 1Aa) and C-DOR
sion in the dorsal horn/spinal trigeminal nucleus, for (Figure 1Ab) antibodies, we observed a similar vesicular
example, by inhibiting SP release (Jessell and Iversen, distribution of DORs in small neurons. About 51% of
1977; Yaksh et al., 1980). Both  and  opioid receptors counted neuron profiles were DOR immunoreactive (Ir),
(DORs, MORs) are known to be involved in the presynap- and 72% of DOR-Ir neuron profiles were small neuron
tic inhibition of SP and CGRP release (Yaksh et al., 1988; profiles (10–25 m in diameter), contributing to 55% of
Pohl et al., 1989). However, there are reports showing the total number of counted small neuron profiles.
Redistribution of DORs was studied in dissected
DRGs after incubation with a selective DOR agonist,*Correspondence: xu.zhang@ion.ac.cn (X.Z.), zzhou@ion.ac.cn (Z.Z.)
4 These authors contributed equally to this work. deltorphin-I (Delt) (Erspamer et al., 1989). Five minutes
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Figure 1. DOR Redistribution in Small DRG
Neurons and PC12 Cells after Delt Treatment
(A) In the sections of DRGs, vesicular localiza-
tion of DOR is seen in neurons with immuno-
fluorescence using antibodies against
N-DOR (Aa) or C-DOR (Ab). (Ac) DOR-Ir vesi-
cles are localized near the cell surface after
Delt treatment. (Ad) The time course of the
changes in the number of DOR-Ir vesicles in
three zones (Z1–Z3) (1.5 m in width/zone)
shows an increase in DOR-Ir vesicles in Z1
and a decrease in Z2 and Z3. (Ae) The in-
crease in the number of DOR-Ir vesicles in
Z1 is dose dependent 5 min after Delt treat-
ment and saturated at 0.1 M. (Af) The num-
ber of DOR-Ir vesicles in the optic section
through the center of neurons is decreased
in a time- and dose-dependent manner. No
recovery is seen after washout for 30 min
(Wash), and the decrease is blocked by NTI
(5 M NTI for 10 min, 5 M NTI  1 M Delt
for 5 min). *p  0.05; **p  0.01 as compared
with the control. Bar indicates 7 m in
(Aa)–(Ac).
(B) HA-DOR-Ir vesicles are localized in the
perinuclear region of the transfected PC12
cell (Ba) and approach the cell surface (arrow)
after Delt treatment (Bb). Bar indicates 10.5
m in (Ba) and (Bb).
(C) Western blotting shows a band detected
by N-DOR antibody in cell lines and DRGs.
after Delt stimulation, DORs were seen near the cell tagged DORs (HA-DOR). PC12 cells are known to con-
tain LDCVs (Kasai, 1999). HA immunolabeling showedsurface in many small neuron profiles (Figure 1Ac). By
counting the number of DOR-Ir vesicles in three zones a perinuclear distribution of HA-DOR prior to Delt appli-
cation (Figure 1Ba). Following exposure to Delt, HA-(Z1–Z3) at increasing distances from the cell surface,
we found a clear movement of DOR-Ir vesicles toward DORs were observed closer to the cell surface (Figure
1Bb). Finally, the specificity of the DOR antibodies wasthe cell surface (Figure 1Ad). This redistribution was
dose dependent and saturated at 0.1 M Delt (Figure tested with Western blotting. A specific band of protein
(60 kDa) was detected with DOR antibodies in cell1Ae). The total number of DOR-Ir vesicles was de-
creased and did not recover after washout. This effect homogenates obtained from PC12 cells, HA-DOR-trans-
fected HEK293 cells, as well as DRGs (Figure 1C). Pread-of DOR was attenuated by naltrindole (NTI), a selective
DOR antagonist (Figure 1Af). Redistribution of DORs sorption of antibodies with DOR peptide antigen abol-
ished the labeling.was also examined using a pheochromocytoma cell line
(PC12 cells) following transfection with HA epitope- The ultrastructural localization of DORs in small neu-
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Figure 2. Ultrastructural Localization of DOR in Small DRG Neurons and PC12 Cells
(A) Preembedding immunogold-silver labeling shows that DORs are associated with the membrane of a LDCV (arrow) (Aa) and a small lucent
vesicle (arrowhead) (Ab) and form clusters on the plasmalemma (arrows) (Ac). Delt increases DOR labeling at the cluster (arrow) (Ad and Ah),
in internalizing coated-vesicles (Ae), endosomes (arrowhead) (Af and Ai), and multivesicular bodies (MVBs) (arrowhead) near the cell surface
(Ag and Ai).
(B) In PC12 cells, DOR shown with DOR antibody is associated with the membrane of LDCVs (Ba). (Bb and Bc) In HA-DOR transfected PC12
cells, DORs shown with HA antibody are also associated with the membrane of LDCVs, and a few HA-DORs appear on the cell surface. Delt
increases the number of HA-DOR clusters (Bd and Bf) and exocytosis of HA-DOR-Ir LDCV (Be). (Bg) HA-DOR in each cluster is slightly
increased. *p  0.05; **p  0.01 as compared with the control. Bars indicate 100 nm in (Aa)–(Ad) and (Ba)–(Be); 200 nm in (Ae)–(Ag).
rons was studied with preembedding immunogold-silver and 2Bg). Apparent exocytosis and internalization of
HA-DORs were seen (Figures 2Bd–2Bg).labeling. We found that DORs were associated with the
rough endoplasmic reticulum and Golgi complex, the
membrane of LDCVs (Figure 2Aa), and some small lucent DOR-Mediated Exocytosis and Plasma Membrane
vesicles (81  4 nm in diameter, n  20) (Figure 2Ab), Insertion of DORs
as well as being scattered throughout the cytoplasm To determine whether the redistribution of vesicles
without apparent association to any cellular structures. eventually results in exocytosis, we used patch-clamp
The latter gold particles may represent DORs in the technique to measure the change in cell membrane ca-
constitutive pathway. In these neurons (n  20), 61%  pacitance (Cm) (Neher and Marty, 1982) in response to
4% of LDCVs contained DORs. A low density of DORs Delt, which reflects the change in the area of plasma
was also observed along the plasma membrane, often membrane as a result of vesicular exocytosis or endocy-
in clusters (0.4  0.1 cluster/m, n  30) labeled by tosis. Dissociated small DRG neurons (14.6  0.8 m in
more than one gold-silver particle (Figures 2Ac and 2Ah). diameter) were whole-cell voltage-clamped at 70mV.
Five minutes after Delt stimulation, the intensity of DOR Averaged Cm of these cells was 12.1  0.6 pF (n  41).
labeling in each cluster was increased, although the One micromolar Delt induced a gradual increase in Cm
number of clusters along the cell surface (0.5  0.1 that lasted for at least 15 min (Figure 3Aa). LDCVs had
cluster/m, n  30) was not significantly changed (Fig- an average diameter of 111  7 nm (n  20), which
ures 2Ad and 2Ah). We also found DORs in some coated corresponded to0.37 fF. At 1 min after Delt treatment,
vesicles (Figure 2Ae), endosomes, and multivesicular the averaged increase in Cm was 117.5 fF (n  20)
bodies (Figures 2Af, 2Ag, and 2Ai) near the cell surface, (Figure 3Ab), corresponding to exocytosis of 318 LDCVs.
suggesting that, accompanying DOR insertion, there is During the first 5 s, the average secretion rate was 2.7
also an increased DOR internalization. In PC12 cells, a fF/s (7 LDCV/s) (Figure 3Ac). The average rate de-
similar subcellular localization of DORs was seen with creased to 1.1 fF/s (3 LDCV/s) at 150 s and remained
DOR antibody (Figure 2Ba). In HA-DOR-transfected at that level. Thus, the Delt-induced release rate is much
PC12 cells, HA-DOR also associated with LDCVs and lower than that induced by depolarization (1425 fF/s) in
was scattered in cytoplasm (Figures 2Bb and 2Bc), fur- these neurons (Huang and Neher, 1996). One micromolar
ther confirming the subcellular localization of DORs. Five Delt yielded saturating responses in terms of both the
minutes after applying Delt, the number of HA-DOR clus- percentage of responding cells (Figure 3Ad) and in-
crease of Cm level (Figure 3Ae) 1 min after treatment.ters was increased on the cell surface (Figures 2Bd, 2Bf,
Neuron
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Figure 3. DOR Agonist-Induced Exocytosis
and DOR Insertion in Small DRG Neurons and
PC12 Cells
(A) Delt increases Cm of a neuron (Gm, mem-
brane conductance; Gs, series conductance)
(Aa). (Ab) Delt-induced increase in Cm is con-
stant (n 20) (Ac) with a relatively fast secre-
tion rate in the first 15 s, which gradually de-
creases and maintains at a lower rate after
150 s. The increase in Cm is dose dependent
with regard to the number of responding cells
(Ad) and increase in Cm (Ae) 1 min after Delt
application, and saturated at 1 nM. (Af) L-ENK
also increases Cm. NTI attenuates Delt-
induced increase in Cm. **p  0.01 as com-
pared with the control (Ae) or Delt treatment
(Af). The number of tested cells is indicated
in the columns.
(B) A similar increase in Cm is seen in PC12
cells.
(C) Dissociated neurons (Ca–Cc) and PC12
cells (Cd and Ce) are incubated with the anti-
body against N-DOR (DOR Ab) (Ca and Cd)
or N-DOR antibody and Delt (Cb and Ce), and
immunostained. (Ca and Cd) DOR is hardly
seen on the cell surface of control cells. Delt
increases DOR labeling near the cell surface
of small neurons (arrowhead) in a time-
dependent manner (Cb and Cc), and both
near the cell surface (arrowhead) and in the
cytoplasm (arrow) of PC12 cells (Ce). *p 
0.05; **p 0.01 as compared with the control.
Bars indicate 14 m in (Ca) and (Cb); 10 m
in (Cd) and (Ce).
(D) Cell surface biotinylation and Western
blotting are performed with dissociated DRG
neurons, and the membrane fraction is
probed for DOR and actin. Biotinylation is
performed at 4C for 45 min (lane 1), for an
additional 10 min at 37C (lane 2), during a 10
min Delt stimulation at 37C and following 45
min at 4C after stimulation (lane 3), or for
only 45 min at 4C after stimulation (lane 4).
Immunoblotting shows a DOR-Ir band (60
kDa) in the membrane fraction. An additional
10 min biotinylation at 37C (lane 2) does not
significantly change DOR level compared
with lane 1. DOR level is markedly increased
when biotinylation is performed over Delt
stimulation (lane 3), whereas only a slight in-
crease in DOR level is seen when biotinylation
is performed after stimulation (lane 4). The
actin-Ir band (40 kDa) is weak, without ap-
parent differences among groups. The level
of DOR relative to actin in lane 3 is compared
with that of lane 2, and lane 4 is compared
with lane 1; * p  0.05.
Leucine-Enkephalin (L-ENK) also increased Cm (Figure N-DOR. Insertion of DORs into the plasma membrane
should result in extracellular exposure of their amino3Af), which was less pronounced than the increase in-
duced by Delt at the same concentration. The effect of terminus, allowing detection with this antibody in non-
permeablized cells. In the absence of Delt, we observedDelt on Cm was abolished by NTI (Figure 3Af). A similar
Delt-induced increase in Cm was also observed in PC12 only a weak surface N-DOR staining in 13% of small
neurons (Figure 3Ca). However, N-DOR surface stainingcells (Figure 3B). These results indicate that DOR activa-
tion results in a slow exocytosis. was observed in 53% of small neurons 5 or 15 min after
Delt treatment, with a higher intensity at 15 min (FiguresTo further examine whether the translocation and exo-
cytosis were accompanied by DOR insertion, we used a 3Cb and 3Cc). Similarly, only very weak N-DOR surface
staining was normally present in PC12 cells (Figure 3Cd).modified immunostaining method to assess the surface
appearance of DOR in dissociated neurons. Neurons Fifteen minutes after Delt stimulation, N-DOR staining
was increased near the cell surface with a patch-likewere incubated with both Delt and the antibody against
 Opioid Receptor Insertion and Peptide Secretion
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distribution, and internalized DOR was seen in vesicular 4Ac), indicating a requirement of Ca2 influx. When the
inositol 1,4,5-trisphosphate receptor (IP3-R) antagoniststructures in the cytoplasm (Figure 3Ce). These results
are consistent with the notion that DORs are inserted xestospongin C (XeC) (Gafni et al., 1997) was applied
intracellularly, the Delt-induced increase in Cm wasinto the plasma membrane following exocytosis.
The level of surface DORs was further measured in largely abolished (Figure 4Ac). Moreover, Delt-induced
increases in [Ca2]i were prevented by XeC and attenu-the plasma membrane fraction of the homogenates ob-
tained from dissociated DRG neurons by cell surface ated by puffing Ca2-free ECS (Figure 4Ad) (n 4). These
results indicate that DOR-mediated exocytosis is de-biotinylation and Western blotting. In control cells, DOR
was detected in the biotinylated membrane fraction after pendent on both Ca2 release from IP3-sensitive stores
and Ca2 influx.biotinylation of the cells at 4C for 45 min, a condition
that prevents insertion or internalization of receptors To directly examine the relationship between [Ca2]i
and insertion of DORs, we studied DOR redistribution(Figure 3D, lane 1). An additional 10 min of biotinylation
at 37C did not affect the total surface pool detected in dissociated small DRG neurons after treatment with
several drugs that affect [Ca2]i. We counted neuronsby this method, suggesting existence of a steady-state
DOR level on the cell surface (Figure 3D, lane 2). In order that exhibited predominantly cytoplasmic DOR staining
(Figure 4Ba, “Inside”), predominantly surface-associ-to monitor DORs inserted into the plasma membrane in
response to agonist stimulation, biotinylation was car- ated staining (Figure 4Bb, “Surface”), or both surface-
associated and cytoplasmic staining (Figure 4Bc, “Sur-ried out at 37C for 10 min in the presence of Delt,
followed by biotinylation at 4C for 45 min. We observed face/Inside”). Delt-induced DOR redistribution toward
the surface was attenuated in the Ca2-free bath (Figurea DOR-Ir band (60 kDa) in the biotinylated membrane
fraction that had a level at 220%  23% (n  3) of the 4Bd). When the intracellular Ca2 store was depleted
with thapsigargin or when IP3 receptor-mediated Ca2control (Figure 3D, lane 3). However, when the same
procedure was carried out in the absence of biotinyla- release was blocked with XeC, DOR redistribution was
largely abolished (Figure 4Bd). Finally, treatment withtion during Delt treatment, the DOR level was only
128% 9% of the control (Figure 3D, lane 4). The differ- SKF 96365, a blocker of the store-operated Ca2 channel
(Rink, 1990), also reduced DOR redistribution (Figureence between the latter two results represents the num-
ber of DORs internalized during the period of Delt treat- 4Bd). The results of cell surface biotinylation and West-
ern blotting also showed that the DOR-mediated in-ment. This indicates a substantial internalization of
DORs, although the total level of surface DORs was crease in the level of surface DORs was attenuated by
incubation with XeC or Ca2-free ECS (Figure 4C). Takenelevated by the agonist stimulation. Furthermore, Delt
did not affect the total amount of DORs in the cell ho- together, these data indicate that DOR redistribution
depends on both Ca2 release from intracellular storesmogenate (data not shown). Immunoblotting the same
samples with three different DOR antibodies yielded and Ca2 influx.
quantitatively similar results, and the bands were elimi-
nated by preadsorption of the antibodies with the re- Comparison with DOR Redistribution Mediated
spective peptide antigen. Taken together, these results by VR1, P2Y1-R, and Depolarization
provide biochemical confirmation that new DORs are In order to determine whether the above-observed DOR-
inserted into the plasma membrane during agonist stim- mediated DOR redistribution represents a novel form of
ulation and that DOR internalization occurs concur- regulation of DOR trafficking, we examined DOR inser-
rently. tion in small DRG neurons induced by depolarization
and nociceptive stimuli. The capsaicin receptor VR1 is
a nonselective cation channel expressed in small DRGInvolvement of Ca2 in DOR
Agonist-Induced DOR Insertion neurons and mediates Ca2 influx (Caterina et al., 1997).
Using immunostaining, we observed 45% 3% of neu-Does agonist-induced DOR insertion reflect Ca2-regu-
lated exocytosis? We addressed this question by study- ron profiles expressing VR1, and these were mainly
small neuron profiles. Among them, 90%  2% con-ing involvement of Ca2 in agonist-induced DOR inser-
tion. The change in the intracellular free Ca2 ([Ca2]i) tained DORs (Figure 5Aa). In these cells, VR1s distrib-
uted near the cell surface and in cytoplasm, but werelevel was measured concurrently with the Cm measure-
ment, using the microfluorometric technique. With the not colocalized with DOR in the vesicles. Furthermore,
Delt increased Cm in 89% of small neurons in whichloading of the fluorescent indicator fura-2 through the
whole-cell recording pipette, Delt-induced elevation of capsaicin yielded inward currents (Figure 5Ab) (n  20).
We found P2Y1-R in 29%  3% of small neuron pro-[Ca2]i was readily detected in cells voltage-clamped
at 70mV, i.e., with most voltage-gated Ca2 channels files, and 92%  4% of them contained DORs (Figure
5Ba). A P2Y1-R agonist, 2-MeSADP, increased Cm in 45%closed. In parallel to the increase in Cm, Delt induced a
slow and persistent increase in [Ca2]i (Figure 4Aa). of small neurons (n29) (Figures 5Bb–5Be), which could
be blocked by the P2Y1-R antagonist MRS 2179 (FigureThere was a linear correlation between the increases in
Cm and [Ca2]i 1 min after Delt treatment (Figure 4Ab). 5Be). The 2-MeSADP-induced increase in Cm was less
pronounced than that by Delt at 1 min after treatmentFurthermore, following whole-cell loading with EGTA, a
slow Ca2 chelator, we failed to detect any change of (Figure 5Bc). In the first 5 s, P2Y1-R-mediated exocytosis
was similar to that induced by Delt (Figures 5Bc andCm in response to Delt, suggesting that Ca2 elevation
was required for Delt-induced exocytosis (data not 5Bd). However, the averaged rate of P2Y1-R-induced
exocytosis decreased sharply within 30 s, followed byshown). Puffing Delt in Ca2-free extracellular solution
(ECS) attenuated the Delt-induced increase in Cm (Figure a gradual reduction from 1.3 fF/s (3.5 LDCV/s) at 90 s
Neuron
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Figure 4. Correlation between DOR Agonist-
Induced [Ca2]i Elevation and DOR Redistri-
bution in Small DRG Neurons
(A) Delt increases Cm and [Ca2]i in a neuron
(Aa). (Ab) Increases in Cm and [Ca2]i are in a
linear relationship 1 min after applying Delt.
(Ac) The DOR-mediated increase in Cm is at-
tenuated by puffing Ca2-free ECS and
blocked by IP3-R blocker, XeC. (Ad) In a small
neuron, blocking IP3-R prevents the Delt-
induced increase in [Ca2]i, and the Delt-
induced increase in [Ca2]i is attenuated by
a rapid switch to Ca2-free ECS.
(B) Vesicular localization of DOR (arrow) is
seen in the cytoplasm (“Inside”) of a control
neuron (Ba and Bd). After Delt (Bb and Bd)
or L-ENK (Bc and Bd) treatment, DOR is seen
almost exclusively on the cell surface (arrow-
head) (“Surface”) (Bb) or on the cell surface
(arrowhead) and inside the neuron (arrow)
(“Surface/Inside”) (Bc). (Bd) Delt- (2) and
L-ENK- (3) induced DOR redistribution is at-
tenuated by depletion of extracellular (4 and
5) or intracellular Ca2 (6), XeC (7), and SKF
(8). *p  0.05; **p  0.01 as compared with
the control. Bar indicates 7 m in (Ba)–(Bc).
(C) Cell surface biotinylation is performed
over different treatments for 10 min at 37C
and is followed by biotinylation at 4C for 45
min. Immunoblotting shows that the increase
in DOR levels in the membrane fraction (lane
1) is attenuated by incubation with XeC (lane
2) or Ca2-free ECS (lane 3). The level of DOR
relative to actin in lanes 1–3 is compared,
respectively, with the control, *p  0.05.
to 0.2 fF/s (0.5 LDCV/s) at 5 min (Figure 5Bd). This Delt- and deplorization-induced exocytosis occurs in
small neurons, we measured changes in Cm caused bytime course is different from DOR-mediated steady exo-
cytosis over the same time period (Figure 3Ac). It has the depolarization and subsequently by Delt. In agree-
ment with findings in rat DRG neurons (Huang andbeen reported that activation of P2Y1-R results in Ca2
release from IP3-sensitive stores in DRG neurons (Usa- Neher, 1996), we found that depolarization caused a Cm
increase and a corresponding elevation of [Ca2]i whenchev et al., 2002). The P2Y1-R-mediated increase in Cm
was attenuated by puffing Ca2-free ECS, but was only repeated depolarizations (70 to 0mV, 50–200 ms) were
applied (data not shown). A short single step pulse (70partially blocked by XeC (Figure 5Be), which is again
different from the complete blockade of DOR-mediated to 0mV, 50 ms) was applied to determine depolarization-
induced exocytosis before Delt was applied. Among 37effects by XeC (Figure 4Ac).
Deplorization is known to increase Ca2 influx and cells tested, 46% showed increases in Cm by step-depo-
larization and Delt (Figure 5C), 11% only by Delt, andneuropeptide release from DRG neurons (Scroggs and
Fox, 1992; Huang and Neher, 1996). To examine whether 32% only by the step pulse. Depolarization-induced in-
 Opioid Receptor Insertion and Peptide Secretion
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Figure 5. Cellular Basis for Correlation Be-
tween DOR, VR1, P2Y1-R, and Depolarization
in Small DRG Neurons
(A) Double-immunofluorescence shows that
DOR (in red) colocalizes with VR1 (in green)
in a neuron (Aa). (Ab) In the same neuron,
Delt increases Cm, and capsaicin induces an
inward current. Bar indicates 5 m in (Aa).
(B) Two adjacent sections stained with the
immunoperoxidase method show DOR and
P2Y1-R in the same neuron (Ba). (Bb) P2Y1-R
agonist 2-MeSADP induces an increase in Cm.
Quantification shows averaged amplitudes of
Cm (Bc) and secretion rate (Bd) mediated by
P2Y1-R (n  10). Secretion rate is relatively
fast during the first 10 s and reduced to very
low levels at 5 min. (Be) The increase in Cm
is blocked with antagonist MRS 2179 (MRS),
attenuated by puffing Ca2-free ECS, and
only partially blocked by XeC. The number of
tested cells is indicated in the column. **p 
0.01 as compared with the group (1). Bar indi-
cates 5 m in (Ba).
(C) A single-pulse depolarization rapidly in-
creases Cm, and Delt increases Cm in the same
neuron.
crease in Cm was blocked by puffing Ca2-free ECS, but surmised that the differences in [Ca2]i changes might
account for the distinct patterns of DOR redistributionnot by XeC.
To further distinguish the mechanism of agonist- induced by DOR agonists. Therefore, we compared the
time course of Delt-, capsaicin-, 2-MeSADP-, and highinduced DOR insertion, we compared capsaicin-, ATP-,
and depolarization-induced DOR redistribution. Using K-induced changes in [Ca2]i in small neurons (Figure
6B). Capsaicin induced a marked increase in [Ca2]imethods described above, we found that capsaicin,
2-MeSADP, and high K (40 mM KCl) caused DOR redis- (660  90 nM, n  10), with a rapid rise (18  2 nM/s)
immediately after stimulation, followed by a prolongedtribution (Figures 6A). However, both capsaicin- and de-
polarization-induced DOR redistribution were attenu- period of relatively stable levels of [Ca2]i (450 90 nM).
A similar pattern of [Ca2]i changes was observed afterated by Ca2-free ECS, but were not affected by the
depletion of intracellular Ca2 stores with thapsigargin, treatments with 2-MeSADP and high K. In contrast,
Delt induced a slow (5  1 nM/s, n  13) and long-blockade of IP3-R with XeC, or application of SKF 96365.
For P2Y1-R-mediated DOR redistribution, Ca2-free ECS lasting increase in [Ca2]i, with the peak value at 15 min
(250  30 nM), much lower than the plateau value ofand SKF 96365 were effective in blocking DOR redistri-
bution, but only about 71% of DOR redistribution was [Ca2]i induced by capsaicin and high K. The transient
and high-level increase in [Ca2]i induced by capsaicin,blocked by thapsigargin and only about 52% by XeC.
These results on the dependence of Ca2 suggest that 2-MeSADP, and high K correlates well with the rapid
DOR redistribution, whereas DOR-induced prolongedDelt-induced DOR redistribution is distinctly different
from those mediated by VR1, P2Y1-R, or depolarization. and low-level increase of Ca2 correlates well with a
slow and long-lasting DOR redistribution.The time courses of capsaicin-, 2-MeSADP-, and de-
polarization-induced DOR redistribution were com- Using cell surface biotinylation and Western blotting,
we found that a 10 min treatment of capsaicin,pared with that induced by Delt (Figure 6A). Apparent
DOR redistribution was seen 30 s after capsaicin and 2-MeSADP, and high K increased DOR levels on the cell
surface of DRG neurons (Figure 6C). However, activating2-MeSADP treatments and saturated within 5 min. High
K caused the most rapid DOR redistribution, which DOR, VR1 and P2Y1-R, and high K stimulation did not
significantly alter the levels of P2Y1-R and VR1 on thewas completed within 30 s. In contrast, apparent DOR-
mediated DOR redistribution was observed after 5 min. cell surface (Figure 6C), consistent with the immunocy-
tochemical results (data not shown). These findings sug-Thus, capsaicin, 2-MeSADP, and depolarization in-
duced more rapid DOR redistributions than Delt. We gest that this mechanism of DOR insertion is specifically
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Figure 6. Comparison between the Effects of
Activation of DOR, VR1, and P2Y1-R, or Depo-
larization on DOR Redistribution and [Ca2]i
in Small DRG Neurons
(A) Delt induces a slow and long-lasting in-
crease in surface expression of DOR. In con-
trast, capsaicin, 2-MeSADP, and high K in-
duce apparent DOR redistribution 30 s after
treatment. DOR redistribution is achieved
within 5 min for VR1 and P2Y1-R, and within
30 s for high K. *p  0.05; **p  0.01 as
compared with the control.
(B) The time-curves of averaged increase in
[Ca2]i (Ba) and the rate of change (Bb) during
15 min treatments show that high K induces
the most rapid and largest rise of [Ca2]i
within seconds, followed by a relatively lower
[Ca2]i (n  10), and both capsaicin (n  10)
and 2-MeSADP (n  15) induce a more rapid
and larger rise of [Ca2]i. Delt induces a slow,
small, and long-lasting increase in [Ca2]i (n
13).
(C) Cell surface biotinylation is performed
over different treatments for 10 min at 37C
and is followed by biotinylation at 4C for 45
min. Immunoblotting shows that VR1 and
P2Y1-R agonists and high K cause increases
in DOR level in the membrane fraction. No
apparent changes in the levels of VR1 (90
kDa) and P2Y1-R (42 kDa) are seen. The
level of DOR relative to actin in lanes 1–4 is
compared with the control; *p  0.05.
related to LDCV-bound DORs, but are not of significance absent in the cytoplasm, with only a few vesicles found
near the cell surface (Figure 7Ac).for VR1s and P2Y1-Rs, which are not colocalized with
DOR in LDCVs. To further verify that the secretion of LDCVs corre-
sponds to the increase in Cm, we also counted the num-
ber of LDCVs in dissociated small neurons and the neu-
DOR-Mediated Neuropeptide Secretion rons treated with Delt for 1 min. Electron microscopy
To establish a possible relationship between the distri- showed that 42%  2% of LDCVs contained CGRP in
butions of DOR and neuropeptides, we examined the control small neuron profiles (n  10), with a similar
localization of DOR and CGRP in DRG sections. About proportion of CGRP-Ir LDCVs in 1 M Delt-treated small
84% of DOR-Ir small neuron profiles expressed CGRP. neuron profiles. Using confocal microscopy, the number
Colocalization of DOR and CGRP was also observed in of CGRP-Ir LDCVs was counted in both control and 1M
vesicles; thus, 82%  2% of CGRP-Ir LDCVs contained Delt-treated DOR and CGRP-Ir small neurons (n  23/
DOR and 86%  1% of DOR-Ir LDCVs contained CGRP group). The number of LDCVs per neuron was estimated
(Figure 7Aa). Furthermore, combining preembedding im- from the number of CGRP-Ir LDCVs and the mean per-
munogold-silver labeling with postembedding immuno- centage of CGRP-Ir LDCVs. These estimates yielded
gold labeling, we observed that DORs associated with 503  63 LDCVs/neuron in control cells and 190  24
the membrane of CGRP-Ir LDCVs (Figure 7Ab). Incubat- LDCVs/neuron at 1 min after Delt treatment. This aver-
ing DRGs with Delt caused a movement of DOR and aged loss of 313 LDCVs/neuron was in good agreement
CGRP-Ir vesicles toward the cell surface, with an in- with the number of secreted LDCVs estimated by the
crease in DOR vesicular structures near the cell surface Delt-induced increases in Cm, suggesting that the latter
(Figures 7Ac and 7Ad). There was a time- and dose- represents exocytosis of LDCVs.
dependent loss of CGRP-Ir LDCVs in DOR-Ir small neu- Finally, we used radio-immunoassay (RIA) to measure
ron profiles (Figure 7Ae), and this loss was blocked by CGRP level in the incubation medium of dissociated
neurons (Figure 7B). After incubation with 1 M Delt orNTI. In some neuron profiles, the vesicles were largely
 Opioid Receptor Insertion and Peptide Secretion
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Figure 7. Activation of DOR-Induced CGRP Release in DRG Neurons
(A) Double-immunofluorescence shows that CGRP (in red) and DOR (in green) colocalize in vesicles (arrow) in control small neurons (Aa) and
in some vesicles near the cell surface (arrow) 5 min after 1 M Delt application (Ac). The double arrowhead points to a vesicle containing
CGRP, and the arrowhead points to DOR. (Ab) Immunogold-silver labeling shows DORs (arrowhead) on the membrane of a LDCV containing
CGRP (15 nm gold particles) (arrow). Bars indicate 8 m in (Aa) and (Ac); 50 nm in (Ab). (Ad) The number of vesicles containing CGRP and
DOR or DOR alone is increased in Z1 after Delt treatment. (Ae) The total number of CGRP-Ir vesicles in the optic section through the center
of small neurons is decreased in a time- and dose-dependent manner after Delt treatment, an effect blocked by 5 M NTI.
(B) Radio-immunoassay shows increases in the CGRP level in the incubation medium 10 min after 1 M Delt or L-ENK treatment, which is
abolished by NTI (5 M NTI for 10 min, 5 M NTI  1 M Delt for 10 min). Treatment of 40 mM KCl for 10 min also elevates the CGRP level.
*p  0.05; **p  0.01, as compared with the control.
L-ENK for 10 min, CGRP level was increased by about In this study, DOR insertion is examined by immuno-
labeling, patch-clamp membrane capacitance tech-50% in the Delt-treated group, with a less pronounced
effect of L-ENK. This effect was blocked by NTI. High nique (Gillis, 1995), and biochemical methods. The pro-
longed DOR agonist-induced increase in Cm suggests aK also increased the CGRP level.
sustained increase in the number of vesicles undergoing
exocytosis, which correlates well with increased DORDiscussion
insertion. However, the increase in Cm was faster than
the apparent appearance of DOR on the cell surfaceRecent evidence from a number of systems has indi-
cated that receptor insertion is highly regulated in neu- and occurred at a lower Delt concentration. The likely
explanations are that Cm measurement is more sensitiverons. For example, activation of the NMDA receptor in-
duces AMPA receptor redistribution (Lissin et al., 1999; than receptor immunolabeling, or the early increase in
Cm may represent the fusion of small vesicles rather thanShi et al., 1999; Lu et al., 2001; Sheng and Lee, 2001),
and depolarization and cAMP elevation trigger insertion LDCVs, the latter perhaps being less sensitive to Ca2
than small vesicles (Kasai, 1999). On the other hand,of TrkB receptor (Meyer-Franke et al., 1998). Treatment
with morphine for 48 hr causes insertion of DORs in the LDCVs near plasma membrane could undergo exo-
cytosis during the early period, since neuropeptides canconstitutive pathway (Cahill et al., 2001). In the present
study, we demonstrated a novel positive-feedback also be released on a millisecond time scale (Whim and
Moss, 2001).mechanism for regulating insertion of DORs. Agonist-
induced activation of DORs results in insertion of DORs In general, DORs will be internalized when they inter-
act with the agonist. Both recycling of DORs in trans-in the regulated pathway, which in turn leads to further
DOR insertion. Both the exogenous DOR agonist Delt fected N18TG2 (Trapaidze et al., 2000) and COS-7 (Gau-
driault et al., 1997) cells, and a nonrecycling pathwayand L-ENK, an endogenous ligand enriched in local neu-
rons in the spinal dorsal horn (Ho¨kfelt et al., 1977), can of DORs in HEK293 cells (Tsao and von Zastrow, 2000;
Whistler et al., 2002) have been described. In agreementactivate this mechanism. We found a potential link be-
tween DOR insertion and neuropeptide release, based with the latter reports, the present morphological and
biochemical results show that many of the newly in-on the physical association of DORs with LDCVs. As a
consequence of DOR activation, peptides stored in the serted DORs are soon internalized. The appearance of
internalized DORs in multivesicular bodies (Smith andLDCVs are released.
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Farquhar, 1966) is consistent with routing of DORs along
the nonrecycling pathway in DRG neurons. In the pres-
ence of DOR internalization, membrane delivery of DORs
becomes important for maintaining the sensitivity to
DOR agonists and the long-term physiological effects
of DORs, such as regulating neuropeptide secretion.
Cytoplasmic Ca2 plays an important role in the regu-
lation of vesicle exocytosis (Engisch and Nowycky,
1996; Neher, 1998). Agonist-induced activation of mem-
brane receptors may activate production of IP3 and trig-
ger the release of the intracellular Ca2 stores. Depletion
of the intracellular Ca2 stores may generate a signal
that in turn activates a plasma membrane Ca2 entry
pathway (Putney, 1999). In this study, a correlation be-
Figure 8. Proposed Model of DOR Agonist-Induced DOR Insertiontween the DOR-mediated increase in [Ca2]i and DOR
and Neuropeptide Releaseinsertion was demonstrated. Moreover, DOR-mediated
Colored dots indicate different types of peptide, e.g., SP and CGRP.DOR redistribution involves both intracellular and extra-
cellular Ca2 and can be blocked by XeC, an IP3-R antag-
that DOR activation may trigger a spatiotemporal pat-onist, and SKF96365, a blocker of store-operated Ca2
tern of Ca2 elevation more favorable for exocytosis ofchannels. Furthermore, Delt-induced vesicle fusion and
LDCVs, perhaps by keeping the local concentration ofCa2 elevation could be measured even when the mem-
Ca2 near plasma membrane at an appropriate level, abrane potential was held at a level at which most volt-
pattern that is unresolved by our global Ca2 measure-age-gated Ca2 channels are closed. These data sug-
ments.gest that voltage-dependent Ca2 channels are not
In summary, our results suggest that DOR insertioninvolved and that agonist-induced Ca2 elevation results
is regulated by activation-induced increases in [Ca2]ifrom the release of IP3-sensitive Ca2 stores and Ca2
levels in small DRG neurons. Besides VR1- and P2Y1-entry via voltage-independent Ca2 channels (Putney,
R-mediated, or depolarization-induced DOR insertion,1999).
we found a novel form of DOR-mediated DOR insertion.In contrast to DOR, both VR1 and P2Y1-R mediate a
In our model (Figure 8), we postulate that DOR agonist-rapid Ca2 influx and DOR insertion. Exocytosis medi-
induced DOR insertion is dependent on fusion of theated by P2Y1-R is largely terminated 5 min after stimula-
LDCV and on two sources of Ca2, IP3-sensitive Ca2tion, whereas DOR-mediated exocytosis remains at a
release and Ca2 influx. Activation of DORs triggers re-relative stable rate, which is well-correlated to the time
lease of Ca2 from internal stores and a voltage-gatedcourse of DOR translocation triggered by these two re-
Ca2 channel-independent Ca2 entry, resulting in DORceptors. Moreover, there is an apparent increase in the
insertion and neuropeptide release. Insertion of DORsagonist-induced cell surface expression of DOR, but not
may further amplify the agonist-induced Ca2 signal,in the level of VR1 or P2Y1-R, suggesting that the effects
providing sustained DOR insertion and neuropeptideof VR1 and P2Y1-R are likely to be mediated by receptors
release—a positive feedback process that continues asalready present on the cell surface, independent of new
long as both the agonist and intracellular DORs are avail-receptor insertion. A slow and long-lasting agonist-
able. While activating nociceptors allow a rapid activity-induced increase in [Ca2]i and DOR insertion seem to
dependent regulation, agonist-induced DOR insertionbe specifically related to DOR delivery via the fusion of
provides a cellular mechanism for sustained agonist-LDCVs, in order to maintain the cell’s sensitivity to the
specific neuronal responses. Finally, we note that theseagonist. High K treatment demonstrates that Ca2 in-
findings may provide a novel perspective on the treat-flux through voltage-gated Ca2 channels can also trig-
ment of pain via opiate receptors. Since SP and CGRPger membrane insertion of DORs. Furthermore, depolar-
are pronociceptive neuropeptides, the treatment of in-ization causes a rapid rise in [Ca2]i and DOR insertion,
flammatory pain should not only involve stimulation ofwhich are dependent on voltage-gated Ca2 channels.
MORs but perhaps also blockade of DORs. In fact, Schil-In fact, following prolonged capsaicin treatment and
ler et al. (1999) have developed bifunctional potent anal-depolarization, the global [Ca2]i remained elevated at
gesic molecules DIPP-NH2[	] with a mixed MOR ago-a level much higher than the highest global [Ca2]i eleva-
nist/DOR antagonist profile with a low propensity fortion induced by DOR agonist. However, prolonged cap-
inducing tolerance, dependence, and side effects. It pro-saicin and K treatments do not cause sustained DOR
duces a strong analgesic effect, about three times moreinsertion, whereas DOR insertion does occur at the even
potent than morphine. It is possible that this moleculelower global [Ca2]i induced by activating DORs. In adre-
utilizes the mechanism described here, i.e., the blockadenal chromaffin cells, at [Ca2]i greater than 1–2 M, pro-
of recruitment of DORs and thus of subsequent releaselonged elevation of [Ca2]i produces lower rates of se-
of excitatory peptides, in addition to stimulation ofcretion than transient elevation of [Ca2]i caused by
MORs.release from internal Ca2 stores (Augustine and Neher,
1992). It has also been proposed that in nerve terminals,
Experimental Procedurestransmitter release is triggered by a large, brief, and
sharply localized rise in [Ca2]i, while augmentation is Immunohistochemistry
produced by a smaller, slower, and more diffuse rise in Lumbar (L) 4 and L5 DRGs were dissected from nine groups of male
C57BL mice (15–18 g; 5 mice/group) and kept in oxygenated artificial[Ca2]i (Swandulla et al., 1991). Therefore, it is possible
 Opioid Receptor Insertion and Peptide Secretion
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cerebrospinal fluid (aCSF). Ganglia were incubated with various Electrophysiology
Dissociated small neurons were recorded with standard whole-celldoses of Delt (Bachem), following the time course indicated in Figure
1A, and fixed in 4% paraformaldehyde and 0.02% picric acid for 3 configuration and a holding potential of 70mV using an EPC-9
amplifier (HEKA) and electrodes filled with the internal solution con-hr. Cryostat sections were immunofluorescence labeled (Zhang et
al., 1998) with rabbit (Rb) antibody (Ab) against amino acids (aa) taining 153 mM KCl, 1 mM MgCl2, 10 mM HEPES, and 4 mM ATP
(pH 7.2). The Cm was recorded with XChart extension and analyzed3–17 (1:1600; DiaSorin) or aa 1–60 (1:200; Santa Cruz) of mouse
DOR-I, goat (Go) Ab against amino acids in C-DOR-I (1:100; Santa with Igor software. Cells with an initial series resistance 10 M

were accepted, and no series resistance compensation was used.Cruz), mouse anti-CGRP Ab (1:400; Celltech), or guinea pig anti-
VR1 Ab (1:1000; Chemicon), and examined in a Leica SP2 confocal Drugs were applied with the DAD-12 superfusion system (ALA),
except for XeC, applied via patch-electrode. Only the cells showingmicroscope. To localize P2Y1-R, adjacent 5 m thick sections were
processed for the avidin-biotin-peroxidase complex (Vector) a stable baseline of Cm under the perfusion of ECS were processed
for further treatment. In another group of cells, Cm was recordedmethod with Rb anti-DOR or P2Y1-R Ab (1:500; Moran-Jimenez and
Matute, 2000). Control was done with Ab preabsorbed with 106 M with a PULSE software extension when a single pulse (70 to 0mV,
50 ms) was applied and followed by drug treatment recorded withimmunogenic peptide. The number of vesicles was quantified (mean
number of vesicles/m2  SEM and unpaired t test) in three zones Xchart software. Data were analyzed 1 min after treatment (mean 
SEM and unpaired t test).of the optic section through the center of DOR or DOR/CGRP-Ir
small neurons (1.5 m in width/zone; Figure 1Ad). In each L5 DRG,
50 neurons were randomly selected and analyzed. [Ca 2]i Measurement
Small neurons, loaded with 2.5 M fura-2-AM (Molecular Probes)
for 30 min at 37C, were randomly examined. One micromolar Delt,Electron Microscopy
1 M capsaicin, 10 M 2-MeSADP, or 40 mM KCl was applied viaThree control L5 DRGs and three L5 DRGs treated with 1 M Delt
the superfusion system. Some cells were preincubated with 20 Mfor 5 min were processed for pre-embedding immunogold-silver
XeC for 10 min and then puffed with 20 M XeC and 1 M Delt,labeling with N-DOR Ab or CGRP Ab and were embedded (Zhang
followed by Delt in Ca2-free ECS. The spatially averaged [Ca2]iet al., 1998). Some DOR-labeled ultrathin sections were stained with
was estimated using the microfluormetric ratio method (Zhou andCGRP Ab and immunogold (1:40; Amersham). The numbers of DOR-
Neher, 1993). [Ca2]i sample rate was 0.5 Hz before stimulation andIr clusters along the cell surface, of gold-silver particles/cluster, and
within 1 min after stimulation, and 0.016 Hz 1 min after stimulationof DOR-Ir endosomes and multivesicular bodies in ten small neuron
via the Ca2 imaging system (TILL). To simultaneously record Cmprofiles from each DRG were counted. The percentage of DOR or
and [Ca2]i, 100 M fura-2 salt was dialyzed into cells via the patchCGRP-Ir LDCVs was counted in small neuron profiles. Data were
electrode. The relationship between [Ca2]i and Cm was analyzedprocessed for mean  SEM and unpaired t test.
with linear regression.
[Ca2]i was calculated from ratio R of the fluorescent signals at
Immunolabeling of HA-DOR in PC12 Cells 340 and 380 nm with the equation: [Ca2]i  Keff(R  Rmin)/(Rmax 
HA epitope was tagged at the second N-terminal amino acid of R). For fura-2-AM, we used external calibration Ca2 buffers, 0 Ca2
mouse DOR-I (Pei et al., 1995). PC12 cells were transfected with (10 mM EGTA), high Ca2 (10 mM Ca2, 0 EGTA), and 400 nM Ca2
1.6 g HA-DOR plasmid/5 l Lipofectin reagent (GIBCO) in serum- (3.3 mM Ca2, 6.6 mM EGTA), containing 10M digitonin. Calibration
free DMEM (GIBCO) for 20 hr, and then in DMEM with serum for parameters were Keff (0.51), Rmin (460), and Rmax (1345), when the
48–72 hr. Cells were incubated with ECS containing 150 mM NaCl, intracellular fluorescence signal was stable. For fura-2 salt, we used
5 mM KCl, 1 mM MgCl2, 2.5 mM CaCl2, 10 mM HEPES, and 10 mM in-vitro calibration by adding 10 M fura-2 to the above three known
D-glucose, or with 1 M Delt for 5 min at 37C. Cells were processed Ca2 buffers. The Ca2 buffers (50 l) were put on the coverslip,
for immunofluorescence or preembedding immunogold-silver label- and fluorescence values were read out. Calibration parameters were
ing with Rb anti-HA Ab (1:500; Clontech). Keff (0.61), Rmin (624), and Rmax (1450).
Cell Surface Biotinylation and Western BlottingPreparation of Dissociated Neurons
Dissociated neurons were incubated in ECS or ECS containing dif-The DRGs were digested with 1 mg/ml collagenase type 1A, 0.4
ferent drugs with or without Sulfo-NHS-LC-Biotin (0.5 mg/ml; Pierce)mg/ml trypsin type I, and 0.1 mg/ml DNase I (all Sigma) in DMEM
for 10 min at 37C (Figures 3D, 4C, and 6C), and then in PBS (Ca2/at 37C for 40 min, triturated, and plated on coverslips.
Mg2) containing the biotin for 45 min at 4C. After stopping the
reaction, cells were lysed. Biotinylated proteins (1.6 g/l) were
Immunolabeling of Dissociated Neurons precipitated with ImmunoPure Immobilized Streptavidin (Pierce)
Cells were treated as indicated in Figures 4B and 6A at 37C. L-ENK, overnight at 4C. HA-DOR was transfected into HEK293 cells by
EGTA, thapsigargin, and 2-MeSADP were from Sigma; capsaicin, Ca2 phosphate coprecipitation. Transfected HEK293 cells, PC12
MRS 2179, and SKF 96365 were from Tocris; XeC was from Calbio- cells, and DRGs were sonicated/homogenized and centrifuged.
chem. Cells were immunofluorescence-labeled. Cells exhibiting (1) The samples was loaded on SDS-PAGE, transferred, probed with
predominantly cytoplasmic staining without intensive labeling in Z1 Abs, and visualized with enhanced chemiluminescence (ECL;
(“Inside”), (2) predominantly surface-associated DOR staining in Z1 Roche). Antibodies against DOR (1:3000, DiaSorin; Santa Cruz;
(“Surface”), or (3) both surface-associated and cytoplasmic staining Chemicon), VR1 (1:1000), P2Y1-R (1:100), and actin (1:10000; Santa
(“Surface/Inside”) were quantified among 200 randomly selected Cruz) were used. Control was done with Ab preabsorbed with 106
DOR-Ir small neurons in each treatment of each experiment. Three M immunogenic peptide. Quantification was based on three inde-
experiments were performed. Total number of CGRP-Ir vesicles was pendent experiments. ECL signal intensity of the receptor versus
counted in control neurons and neurons treated with 1 M Delt for actin was quantified with NIH Image program (mean  SEM and
1 min, which were DOR and CGRP-Ir and Z-scanned into series of unpaired t test).
0.5 m thick optic sections from the top to the bottom of the cells
in the confocal microscope. Data were processed for mean  SEM
CGRP RIA
and unpaired t test.
Four independent experiments were carried out. Dissociated L4 and
L5 DRG neurons were incubated with 500 l ECS or ECS containing
1 M Delt, 1 M L-ENK, or 40 mM KCl for 10 min at 37C, orImmunostaining of Inserted DORs
Dissociated neurons and PC12 cells were incubated with 1:50 Rb preincubated with 5 M NTI for 10 min and followed by 500 l 5
M NTI and 1 M Delt for 10 min at 37C. For each test, 500 lanti-N-DOR serum for 15 min at 37C, or together with 1 M Delt
for 5 or 15 min. Cells were fixed and incubated with FITC-anti-Rb incubation solution was collected before and after each treatment,
and CGRP was measured twice in each sample with a RIA Kit (Insti-IgG (1:100; Jackson). Quantification on confocal images was done
by measuring the gray levels in Z1 of 60 randomly selected DOR-Ir tute of Dong Ya Immuno-technique) and quantified (mean  SEM
and unpaired t test).small neurons in each treatment (mean  SEM and unpaired t test).
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